ROCKET PHARMACEUTICALS INC's ticker is and the CUSIP is 77313F956. A total of 3 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $290,655 | -8.6% | 13,500 | +14.4% | 0.00% | – |
Q1 2024 | $317,892 | -95.2% | 11,800 | -94.7% | 0.00% | -100.0% |
Q4 2023 | $6,623,370 | +29.1% | 221,000 | -11.7% | 0.00% | 0.0% |
Q3 2023 | $5,128,647 | +1565.1% | 250,300 | +1196.9% | 0.00% | – |
Q3 2022 | $308,000 | +18.9% | 19,300 | +2.7% | 0.00% | – |
Q2 2022 | $259,000 | – | 18,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
SIMPLEX TRADING, LLC | 4,900 | $67,000 | 0.00% |
JANE STREET GROUP, LLC | 18,800 | $259,000 | 0.00% |